Research output per year
Research output per year
Personal profile
Research interests
Suresh Senan is the Professor of Clinical Experimental Radiotherapy at the Amsterdam University Medical Centers (VUmc location), The Netherlands. He completed training in radiotherapy and oncology in the United Kingdom. His research group is active in lung cancer, use of immune checkpoint inhibitors, magnetic resonance imaging-guided radiotherapy and stereotactic radiotherapy. He is a faculty member for thoracic malignancies at the European Society for Medical Oncology.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Suresh Senan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Implementing a fully computed tomography-free online adaptive palliative radiotherapy: a one-visit workflow
Jaglal, A. T., Nelissen, K. J., van Vlaenderen, A. R. W., de la Fuente, A. L., Schneiders, F. L., van Rossum, P. S. N., Wiersma, J., Verbakel, W. F. A. R., Senan, S., Visser, J. & Versteijne, E., Jan 2026, In: Physics and Imaging in Radiation Oncology. 37, 100896.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
Re-irradiation of adrenal metastases using MR-guided adaptive SABR: A feasible and effective approach in a high-risk population
Palacios, M. A., Bruynzeel, A. M. E., van Rossum, P. S. N., Bohoudi, O., Senan, S. & Schneiders, F. L., 1 Jan 2026, In: Clinical and Translational Radiation Oncology. 56, 101056.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Downloads (Pure) -
Beneficial value of [ 18 F]FDG PET/CT in the follow-up of patients with stage III non-small cell lung cancer (NVALT31-PET study): Study protocol of a multicentre randomised controlled trial
Billingy, N. E., Verberkt, C. A., Bahce, I., Hassing, M. J., Schoorlemmer, J., Sarioglu, M., Senan, S., Aarntzen, E. H. J. G., Comans, E. F. I., Kievit, W., Teerenstra, S., Jacobs, C., Keijser, A., Heuvel, M. M. V. D., Becker-Commissaris, A. & Walraven, I., 25 Jul 2025, In: BMJ open. 15, 7, e103745.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors
Giraud, N., Palacios, M. A., van Sornsen de Koste, J. R., Marzo, A. M., van Rossum, P. S. N., Schneiders, F. L. & Senan, S., Sept 2025, In: Clinical and Translational Radiation Oncology. 54, 101011.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial
Zenke, Y., Shiraishi, Y., Goto, Y., Azuma, K., Okishio, K., Ogino, H., Horio, Y., Oizumi, S., Hayama, M., Nii, M., Harada, M., Mann, H., Olivo, Y. S., Jiang, H. & Senan, S., Nov 2025, In: Cancer science. 116, 11, p. 3171-3184 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure)